← Back to Search

Behavioral Intervention

Acceptance and Commitment Therapy for Cancer-Related Psychological Symptoms

N/A

Waitlist Available

Led By Miryam Yusufov, PhD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial is developing an intervention to help cancer patients cope with psychological symptoms such as thoughts, feelings, emotions, and memories. It will assess the feasibility and acceptability of Acceptance & Commitment Therapy (ACT) to reduce risk of substance use disorder.

Who is the study for?

This trial is for adults over 18 with any type of cancer, expected to live at least 6 more months, and who are on opioid therapy with a risk for substance use disorder. They should be able to do daily activities with little to no help and must understand English well enough for psychotherapy.Check my eligibility

What is being tested?

The study tests Acceptance & Commitment Therapy (ACT) adapted for cancer patients at risk of substance misuse due to opioid pain treatment. It involves six sessions with a psychologist, questionnaires, and an interview after the study.See study design

What are the potential side effects?

Since ACT is a form of talk therapy focusing on mental health, it doesn't have physical side effects like drugs but can bring up strong emotions or distress as patients work through their thoughts and feelings.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility and acceptability of the intervention, as reported on semi-structured exit interviews

Secondary outcome measures

Feasibility and acceptability of the intervention, as reported on the client satisfaction questionnaire - 8 (CSQ-8)

Trial Design

1Treatment groups

Experimental Treatment

Group I: INTERVENTION FOR AVOIDANCE-RELATED OPIOID MISUSEExperimental Treatment1 Intervention

Participants will participate in a six-session behavioral intervention, delivered by a licensed clinical psychologist.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acceptance and Commitment Therapy

2010

Completed Phase 1

~1490

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,935 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,660 Previous Clinical Trials

40,924,259 Total Patients Enrolled

Miryam Yusufov, PhDPrincipal InvestigatorDana-Farber Cancer Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is participation in this clinical trial being sought?

"Affirmative. According to the records on clinicaltrials.gov, this medical trial is still actively recruiting participants. It was first released on February 1st 2023 and updated most recently on December 1st 2022; currently, it aims to enrol 20 patients at one site."

Answered by AI

Does the clinical trial have any age restrictions, such as requiring participants to be over 55 years of age?

"This clinical trial is recruiting individuals who are of age 18 or more, but younger than 99 years."

Answered by AI

Do any vacancies exist for participants in this experiment?

"Correct. Clinicaltrials.gov data verifies that this medical study, first posted on February 1st 2023, is actively searching for participants. In total, the clinical trial seeks out a cohort of 20 patients from one location."

Answered by AI

Who meets the criteria to be eligible for participation in this experiment?

"In order to be suitable for this clinical trial, potential candidates must suffer from a form of cancer and reside between the ages of 18 and 99 years old. The research team is actively searching for 20 participants in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Novel Intervention for Patients With Cancer

Miryam Yusufov, PhD 2023. "A Novel Intervention for Patients With Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05643027.

All > Substance Abuse > Psychological